217 related articles for article (PubMed ID: 31772787)
1. Hyperandrogenism, Elevated 17-Hydroxyprogesterone and Its Urinary Metabolites in a Young Woman with Ovarian Steroid Cell Tumor, Not Otherwise Specified: Case Report and Review of the Literature.
Wong FCK; Chan AZ; Wong WS; Kwan AHW; Law TSM; Chung JPW; Kwok JSS; Chan AOK
Case Rep Endocrinol; 2019; 2019():9237459. PubMed ID: 31772787
[TBL] [Abstract][Full Text] [Related]
2. Ovarian Steroid Cell Tumor Masquerading as Steroid-Unresponsive Congenital Adrenal Hyperplasia.
Driano JE; Creo AL; Kumar S; Chattha AJ; Lteif AN
AACE Clin Case Rep; 2021; 7(4):261-263. PubMed ID: 34307849
[TBL] [Abstract][Full Text] [Related]
3. MORE THAN MEETS THE EYE IN A PATIENT WITH PCOS: ANDROGEN-SECRETING GRANULOSA CELL OVARIAN TUMOR IN A VIRILIZED WOMAN WITH POLYCYSTIC OVARIAN SYNDROME (PCOS).
Harris AA; Kabadi UM
AACE Clin Case Rep; 2020; 6(4):e170-e173. PubMed ID: 32734001
[TBL] [Abstract][Full Text] [Related]
4. [Sertoli-Leydig cell tumour (arrhenoblastoma) in a patient with polycystic ovary syndrome: clinical, ultrasonographic, hormonal and histopathological evaluation].
Puzigaća S; Prelević G; Svetenović Z; Djuricić S; Kokan Dj; Radivojević U
Srp Arh Celok Lek; 2001; 129 Suppl 1():51-5. PubMed ID: 15637992
[TBL] [Abstract][Full Text] [Related]
5. Value of buserelin testing in the evaluation of hirsute women.
Ambrosi B; Re T; Passini E; Bochicchio D; Ferrario R
J Endocrinol Invest; 1996 Apr; 19(4):204-9. PubMed ID: 8862498
[TBL] [Abstract][Full Text] [Related]
6. [Androgen and 17-hydroxyprogesterone concentrations in blood serum versus menstrual patterns in women with polycystic ovary syndrome (PCOS)].
Rudnicka E; Kunicki M; Radowicki S
Ginekol Pol; 2010 Oct; 81(10):745-9. PubMed ID: 21117302
[TBL] [Abstract][Full Text] [Related]
7. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
Markopoulos MC; Rizos D; Valsamakis G; Deligeoroglou E; Grigoriou O; Chrousos GP; Creatsas G; Mastorakos G
J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
[TBL] [Abstract][Full Text] [Related]
8. Adrenal androgenic response to 2-hour ACTH stimulation test in women with PCOS.
Erel CT; Senturk LM; Oral E; Colgar U; Ertungealp E
Gynecol Endocrinol; 1998 Aug; 12(4):223-9. PubMed ID: 9798131
[TBL] [Abstract][Full Text] [Related]
9. Source localization of androgen excess in adolescent girls.
Ibáñez L; Potau N; Zampolli M; Prat N; Gussinyé M; Saenger P; Vicens-Calvet E; Carrascosa A
J Clin Endocrinol Metab; 1994 Dec; 79(6):1778-84. PubMed ID: 7989484
[TBL] [Abstract][Full Text] [Related]
10. Clinical observations and hormone screenings of patients with non-standard hypertrophy of the adrenal cortex.
Franik G; Skałba P
Endokrynol Pol; 2011; 62(3):230-7. PubMed ID: 21717405
[TBL] [Abstract][Full Text] [Related]
11. Ovarian Steroid Cell Tumor (Not Otherwise Specified): A Case Report of Ovarian Hyperandrogenism.
Faten H; Dorra G; Slim C; Wajdi S; Nadia C; Kais C; Tahia B; Mohamed A
Case Rep Oncol Med; 2020; 2020():6970823. PubMed ID: 32328328
[TBL] [Abstract][Full Text] [Related]
12. How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?
Kaltsas GA; Korbonits M; Isidori AM; Webb JA; Trainer PJ; Monson JP; Besser GM; Grossman AB
Clin Endocrinol (Oxf); 2000 Oct; 53(4):493-500. PubMed ID: 11012575
[TBL] [Abstract][Full Text] [Related]
13. An unusual circulating steroid profile in a virilized postmenopausal woman.
Benavent Correro P; Sáenz Valls M; García Cano A; Jiménez Mendiguchia L; Moreno Moreno E; Luque-Ramírez M
Diagnosis (Berl); 2018 Jun; 5(2):83-87. PubMed ID: 29752879
[TBL] [Abstract][Full Text] [Related]
14. Successful laparoscopic resection of virilizing ovarian steroid cell tumor, not otherwise specified, in a 22-year-old woman: a case report and evaluation of the steroidogenic pathway.
Matsukawa J; Takahashi T; Hada Y; Kameda W; Ota K; Fukase M; Takahashi K; Matsuo K; Mizunuma H; Nagase S
Fukushima J Med Sci; 2020 Jan; 65(3):133-139. PubMed ID: 31827013
[TBL] [Abstract][Full Text] [Related]
15. Ultrasonographic appearance of polycystic ovaries is associated with exaggerated ovarian androgen and oestradiol responses to gonadotrophin-releasing hormone agonist in women undergoing assisted reproduction treatment.
Suikkari AM; MacLachlan V; Montalto J; Calderon I; Healy DL; McLachlan RI
Hum Reprod; 1995 Mar; 10(3):513-9. PubMed ID: 7782424
[TBL] [Abstract][Full Text] [Related]
16. Ovarian suppression with triptorelin and adrenal stimulation with adrenocorticotropin in functional hyperadrogenism: role of adrenal and ovarian cytochrome P450c17 alpha.
Escobar-Morreale H; Pazos F; Potau N; García-Robles R; Sancho JM; Varela C
Fertil Steril; 1994 Sep; 62(3):521-30. PubMed ID: 8062947
[TBL] [Abstract][Full Text] [Related]
17. Functional hyperandrogenism detected by corticotropin and GnRH-analogue stimulation tests in women affected by apparently idiopathic hirsutism.
Rossi R; Tauchmanovà L; Luciano A; Valentino R; Savastano S; Battista C; Di Martino M; Lombardi G
J Endocrinol Invest; 2001; 24(7):491-8. PubMed ID: 11508782
[TBL] [Abstract][Full Text] [Related]
18. A comparison between the effects of low dose (1 microg) and standard dose (250 microg) ACTH stimulation tests on adrenal P450c17alpha enzyme activity in women with polycystic ovary syndrome.
Colak R; Keleştimur F; Unlühizarci K; Bayram F; Sahin Y; Tutuş A
Eur J Endocrinol; 2002 Oct; 147(4):473-7. PubMed ID: 12370108
[TBL] [Abstract][Full Text] [Related]
19. Ovarian Leydig cell tumor in a peri-menopausal woman with severe hyperandrogenism and virilization.
Nardo LG; Ray DW; Laing I; Williams C; McVey RJ; Seif MW
Gynecol Endocrinol; 2005 Oct; 21(4):238-41. PubMed ID: 16316848
[TBL] [Abstract][Full Text] [Related]
20. Differential diagnosis of hyperandrogenism in women with polycystic ovary syndrome.
Rachoń D
Exp Clin Endocrinol Diabetes; 2012 Apr; 120(4):205-9. PubMed ID: 22421986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
